Function of CH25H and 25-OHC in immune response and application thereof as immunomodulator in vaccines
An immunomodulator and vaccine technology, applied in the field of biomedicine, to improve the immune effect and reduce the effect of cell proliferation and activation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0044] Example 1 Application of 25-OHC in anti-inflammatory
[0045] The experimental materials used in this embodiment are as follows:
[0046] Cell line: 174×CEM is preserved by our laboratory. It is a fusion cell line of human B lymphocyte line and T lymphocyte line, which is very suitable for the infection experiment of SIV virus. The culture condition of 174×CEM was RPMI 1640 medium containing 10% FBS.
[0047] Chinese macaque PBMCs and mouse lymphocytes: PBMCs were isolated from the whole blood of macaques, and the macaques were raised in the China South African Human Primate Center. Normal mouse spleen lymphocytes were derived from experimental SPF grade C57BL / 6 mice, which were raised in the animal center of Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences. The culture conditions of PBMC and lymphocytes were RPMI 1640 complete medium containing 10% FBS.
[0048] Reagents: OptiPrep™ (Axis-Shield), the main human lymphocyte separation mediu...
Embodiment 2
[0079] Example 2 Application of 25-OHC in Inhibiting Nonspecific Cell Proliferation of Primary Lymphocytes
[0080] method:
[0081] A. Stain mouse spleen single cell suspension or rhesus monkey PBMC according to conventional CFSE experiments
[0082] 1) Separation of lymphocytes by conventional methods, trypan blue staining and cell counting, with 4×10 6 The number of cells (4 wells for each stimulating peptide, 1 million cells / well, 24 wells) is a staining unit. Transfer to a 15 ml centrifuge tube and resuspend with an appropriate volume of RPMI 1640. After centrifugation at 350 g for 5 min, resuspend in 1 ml RPMI 1640.
[0083] 2) Dilute the CFSE stock solution with RPMI1640 to below 2 μmol / L (2 mM CFSE stock solution is diluted 1000 times) and operate in the dark as much as possible.
[0084] 3) Add 1 ml of CFSE diluent to every 1 ml of cell suspension, and mix gently (at this time, the cells are fragile, so the action should be as gentle as possible).
[0085] ...
Embodiment 3
[0102] Example 3: Modulation of vaccine immunogenicity by 25-OHC
[0103] Studies have shown that in vitro cell experiments have shown that excessively high concentrations of 25-OHC often have obvious toxic effects on cells, resulting in cell apoptosis and weakened proliferation. However, no literature has been found to study the in vivo toxicity of 25-OHC exceeding physiological concentrations. The plasma of normal mice contains only a very low concentration of 25-OHC (about 2 ng / ml). In this study, we used continuous tail vein injection of low-dose and high-dose 25-OHC to observe its effect on the immunogenicity of SIV antigen.
[0104] The experimental materials used in this embodiment are as follows:
[0105] Experimental animals: SPF grade C57BL / 6 mice (Beijing Weitong Lihua Experimental Animal Technology Co., Ltd.), raised by the Animal Experiment Center of Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences.
[0106] SIV vaccine (Ad5-SIVenv):...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com